/cdn.vox-cdn.com/uploads/chorus_asset/file/22461476/vpavic_4547_20210421_0131.jpg "Apple AirTag is available at its best price of the year")
An illustration of messenger ribonucleic acid (mRNA)
Kateryna Kon/Science Photo Library/Getty Images
Sixteen people have benefited from an experimental mRNA therapy that replaces a faulty enzyme behind a rare inherited condition, biotech company Moderna announced May 19. This is great news for people with this condition, but its importance extends further: if this type of mRNA therapy proves safe and effective, it could help treat a wide variety of conditions and could even revolutionize medicine.
The people in the trial, ages 1 year and older, have a condition called propionic…
